'Bangavax' gets approval for clinical trial
Published : Wednesday, 16 June, 2021 at 3:27 PM Count : 345
Bangladesh Medical Research Council (BMRC) has decided in principle to approve Globe Biotech's COVID-19 vaccine 'Bangavax' for clinical trial on human body.
The decision was taken at a virtual meeting of on Wednesday.
BMRC Director Professor Ruhul Amin said, "We will approve the vaccine after fulfilling of some conditions."
Getting the final nod from the BMRC, Bangladesh will start administering the vaccine on human body.
Professor Ruhul Amin informed that two more vaccines-- one from China and another from India-- were also taken into consideration for approval.
'Bangavax' is the world's first effective single-dose vaccine made using mRNA technology that has successfully shown strong protection in human cells and animals against the SARS-Cov-2 virus.
Globe Biotech Limited, a Bangladeshi company, has developed this vaccine with its own technology in tandem with world-renowned vaccine developers which also take Bangladesh to a unique height on the world stage.